![](/img/cover-not-exists.png)
DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy
Paul J. M. van de Vaart, Jose Belderbos, Daphne de Jong, Kommer C.A. Sneeuw, Donne Majoor, Harry Bartelink, Adrian C. BeggVolume:
89
Year:
2000
Language:
english
Pages:
7
DOI:
10.1002/(sici)1097-0215(20000320)89:23.0.co;2-j
File:
PDF, 193 KB
english, 2000